Centessa Pharmaceuticals’ mission is to bring impactful new medicines to patients. To accomplish this mission, Centessa conducts clinical trials to evaluate the safety and efficacy and risk / benefit profile of investigational medical products in development. Clinical trials provide a pathway to regulatory approval, which in turn enables access to treatment for most patients. As a result, Centessa focuses its efforts on designing and conducting clinical trials that, if successful, will ultimately lead to regulatory approval and broad patient access.
Centessa recognizes circumstances may arise in which a patient has a serious or life-threatening disease or condition, has exhausted all available therapy options, and is ineligible or unable to participate in a clinical trial. In such a situation and in compliance with any applicable local laws or regulations, a treating physician may seek special access to an investigational product through expanded access (otherwise known as “early access” or “compassionate use”).
Centessa does not currently offer an expanded access program. To learn more about Centessa Pharmaceuticals’ clinical trials, please visit www.clinicaltrials.gov.
If you have any questions about our expanded access policy, please contact us at: ExpandedAccess@centessa.com.
Scroll to Top
This link will leave the Centessa Pharmaceuticals website, opening a new window.
This website is only available to individuals in the United States
